Donald Hooker
Stock Analyst at Keybanc
(2.51)
# 2,403
Out of 4,974 analysts
82
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $7.82 | +1,178.77% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $163.99 | +137.82% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $183.49 | -7.35% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $187.68 | +54.52% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $28.13 | +159.51% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $4.61 | +680.91% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $6.98 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $272.93 | +29.34% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $91.48 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $88.22 | -4.78% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $9.61 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $278.67 | -39.00% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $174.88 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $1.58 | +2,811.39% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $25.85 | - | 1 | Oct 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $486.07 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $7.82
Upside: +1,178.77%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $163.99
Upside: +137.82%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $183.49
Upside: -7.35%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $187.68
Upside: +54.52%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $28.13
Upside: +159.51%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $4.61
Upside: +680.91%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $6.98
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $272.93
Upside: +29.34%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $91.48
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $88.22
Upside: -4.78%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $9.61
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $278.67
Upside: -39.00%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $174.88
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $1.58
Upside: +2,811.39%
Oct 24, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $25.85
Upside: -
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $486.07
Upside: -